Abiomed (ABMD) Financial Analysis & Valuation | Quarter Chart
Abiomed (ABMD)
ABMDPrice: $381.02
Fair Value: 🔒
🔒score
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and se... more
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace... more
Description
Shares
| Market Cap | $17.18B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Devices |
| Country | US | CEO | Michael Minogue |
| IPO Date | 1987-07-29 | CAGR | 0.17% |
| Employees | 2,003 | Website | www.abiomed.com |
| Div. Yield | — | Payout Ratio | — |
| Buy Back Yield | 0.74% | Total Yield | 0.74% |
ABMD chart loading...
Fundamentals
Technicals
| Enterprise Value | $10.96B | P/E Ratio | 65.36 |
| Forward P/E | — | PEG Ratio | — |
| P/S Ratio | 16.65 | P/B Ratio | 11.52 |
| P/CF Ratio | 60.67 | P/FCF Ratio | 68.83 |
| EPS | $5.83 | EPS Growth 1Y | 79.63% |
| EPS Growth 3Y | 21.76% | EPS Growth 5Y | 186.7% |
| Revenue Growth 1Y | 10.32% | Gross Margin | 0.82% |
| Operating Margin | 0.36% | Profit Margin | 0.13% |
| ROE | 0.1% | ROA | 0.08% |
| ROCE | 0.24% | Current Ratio | 7.05 |
| Quick Ratio | 6.37 | Cash Ratio | 0.96 |
| Debt/Equity | — | Interest Coverage | 7.48 |
| Altman Z Score | 68.84 | Piotroski Score | 5 |